Effect of Renal Impairment on Mortality of Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

1 A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy Gynecologic Oncology, May 6, 2013

2 Incidence of Stroke Before and After Dialysis Initiation in Older Patients Journal of the American Society of Nephrology, May 2, 2013

3 A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma Cancer Chemotherapy and Pharmacology, May 14, 2013

4 Charlson Co-morbidity Index and albumin significantly associated with fracture risk in peritoneal dialysis patients Nephrology, May 1, 2013    Review Article

5 Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study The Lancet Oncology, May 3, 2013

6 Renal diseases in haemophilic patients: pathogenesis and clinical management European Journal of Haematology, May 16, 2013
Exclusive Author Commentary

7 212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint British Journal of Cancer, May 2, 2013

8 Psychological and Emotional Status, and Caregiver Burden in Caregivers of Patients With Peritoneal Dialysis Compared With Caregivers of Patients With Renal Transplantation Transplantation Proceedings, April 30, 2013    Review Article

9 Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy? Annals of Surgery, May 16, 2013

10 Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers Gynecologic Oncology, April 30, 2013